| Element List | Current Year | Previous Year | %Change | ||
|---|---|---|---|---|---|
| Sales/Revenue | 1,416.3 | 1,202.3 | 17.8 | ||
| Gross Profit (Loss) | 448.6 | 371.7 | 20.69 | ||
| Operational Profit (Loss) | 219.4 | 187 | 17.33 | ||
| Net Profit (Loss) Attributable to Shareholders of the Issuer | 200.4 | 94.4 | 112.29 | ||
| Total Comprehensive Income Attributable to Shareholders of the Issuer | 207.1 | 98.6 | 110.04 | ||
| Total Shareholders Equity (after Deducting Minority Equity) | 1,979.6 | 717.7 | 175.82 | ||
| Profit (Loss) per Share | 4.54 | 2.7 | |||
| All figures are in (Millions) Saudi Arabia, Riyals | |||||
| Element List | Amount | Percentage of the capital (%) | |
|---|---|---|---|
| Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value | - | - | |
| All figures are in (Millions) Saudi Arabia, Riyals | |||
| Element List | Explanation |
|---|---|
| The reason of the increase (decrease) in the sales/ revenues during the current year compared to the last year | The increase in revenues by 17.8% during the current year compared to the previous year was primarily driven by the continued expansion of the Company’s healthcare services and increased operational capacity across its facilities. This included a significant increase in the utilization of the Rehabilitation Hospital, which recorded year-on-year growth of 52.6%, contributing positively to overall patient volumes and revenues. In addition, Almoosa Health expanded its healthcare network through the opening of two large medical centers in the Eastern Province, namely Al-Nakheel Medical Center in Al Ahsa and Al-Azizyah Medical Center in Al Khobar. These new facilities contributed to increased outpatient volumes, with Al-Nakheel Medical Center achieving operational break-even within less than six months of operations. The Company also expanded its clinical service offerings through the addition of new clinics across multiple specialties, including Dermatology, Pediatrics, ENT, Ophthalmology, Endocrinology, Neurology, and Orthopedics, further enhancing patient access to specialized care. Furthermore, renovation and expansion of surgical departments at Almoosa Health Company increased surgical capacity and improved patient throughput, which contributed to higher patient admissions and overall revenue growth. |
| The reason of the increase (decrease) in the net profit during the current year compared to the last year is | Net profit for FY25 increased by 112.3% year-on-year, primarily driven by higher revenues resulting from increased patient volumes and admissions, as well as a more favorable case mix with a higher proportion of complex and specialized procedures. The increase was also supported by the expansion of clinical services through the addition of new clinics across various specialties, which enhanced service capacity and contributed to higher patient activity. Profitability was further supported by improved operational efficiency and stronger cost management across the Group’s hospitals and medical centers. In addition, the Group recorded lower finance costs following the settlement of certain financing facilities earlier in the year after the IPO, which positively impacted the bottom line. The Company’s operating earnings for the period include a non-cash, unrealized loss of SAR 6.4 million relating to the fair value measurement of its investment in a local fund. Despite the opening of two new medical centers during the year, management maintained close monitoring of operational costs during the ramp-up phase, ensuring that expenses remained aligned with revenue generation. The Group benefited from economies of scale, enabling more efficient utilization of resources and supporting overall profitability growth while Almoosa group continued to expand its spectrum of services and increasing its network. |
| Statement of the type of external auditor's report | Unmodified opinion |
| Comment mentioned in the external auditor’s report, mentioned in any of the following paragraphs (other matter, conservation, notice, disclaimer of opinion, or adverse opinion) | N/A |
| Reclassification of Comparison Items | N/A |
| Additional Information | Performance Highlights – FY 2025 - Strengthened Capital Structure Post-IPO: Following the IPO, Almoosa Health Company settled major loan facilities, significantly reducing finance costs and improving the Company’s financial leverage and profitability. As a result, Net Debt to Equity improved from 1.8x in 2024 to 0.3x in 2025, while Net Debt to EBITDA declined from 4.8x to 2.1x during the same period. The strengthened capital structure provides the Company with substantial financial flexibility, including access to approximately SAR 2 billion in financing facilities, which will support future growth capital expenditure and optimize the Company’s cost of capital. - Expansion of Clinical Network and Growth Pipeline: The Company continued to expand its clinical capabilities and service offerings across its healthcare network. Looking ahead, Almoosa Health plans to open two additional medical centers in 2026 and will continue expanding its network across the Eastern Province as part of its long-term growth strategy. - Acceleration of Strategic Capital Projects: During FY2025, the Company accelerated investment in strategic capital projects, allocating SAR 560.9 million in capital expenditure to advance the construction and development of projects currently in the pipeline, supporting future capacity expansion and long-term growth. - The Board of Directors approved a cash dividend of SAR 0.35 per share, amounting to SAR 15.5 million, for the fourth quarter of 2025, reflecting the Group’s strong financial performance and commitment to delivering value to its shareholders. Almoosa Health intends to hold an Earnings Call tomorrow, Thursday, 12 March 2026, at 2:00 PM (Saudi Time) to address questions from investors and analysts regarding the financial results for FY 2025. Investors can register via the attached invitation. |
| Attached Documents | Attached Documents Attached Documents Attached Documents |
